At Clayton plant, Grifols produces first batch of potential COVID-19 treatment
Date Published:
RESEARCH TRIANGLE PARK – Grifols, a global biotherapeutics company with major operations in North Carolina, has delivered the first batches…
Life Sciences
RTP oncology firm G1 strikes 3rd licensing deal in 3 months, latest one being worth up to $170M
Date Published:
RESEARCH TRIANGLE PARK – G1 Therapeutics has struck another development deal for its oncology portfolio, the latest one announced Monday…
Durham-based Altis Biosystems sells unique human cell platform for more accurate drug-testing
Date Published:
DURHAM — Altis Biosystems, a University of North Carolina at Chapel Hill spinout, has created a unique organ on a…
Patent Issued for 9 Meters Biopharma’s Potential COVID-19 Treatment
Date Published:
Thinking outside the gut, a Raleigh pharmaceutical upstart is landing support for exploring its tissue-tweaking technology as a possible extension…
Durham biotech uses new funding to acquire gene therapy for eye disease
Date Published:
A Hatteras-backed, early-stage life science company has used its new funding to acquire the exclusive rights to gene therapy platform…
Holly Springs’ Avior Bio launches clinical trial of chronic itch therapy
Date Published:
HOLLY SPRINGS — Less than two years after launching, a small Triangle biotech startup is kicking off its first human…
Hatteras backs $3 million seed round for UNC spin-out with stem-cell platform
Date Published:
A Triangle spin-out company looking to develop its stem-cell technology has wrapped up a $3.1 million seed investment led by…
LabCorp gets FDA approval for pooled Covid-19 testing that increases capacity, saves supplies
Date Published:
Seeking to improve turnaround times for Covid-19 testing, Burlington-based LabCorp (NYSE: LH) has received emergency approval from the U.S. Food…
IQVIA Initiative Gives COVID-19 Researchers Free Access to Global Data
Date Published:
Research Triangle Park-based contract research giant IQVIA has launched a program that waives licensing and access fees for approved academic…